We need your views; complete the DECIDE Survey
Decisions in health Care to Introduce or Diffuse Innovations using Evidence (or DECIDE) is a two year study funded by the Health Foundation to investigate the role of evidence in decisions to introduce innovation. This survey is asking for your views about different types of evidence that are used when making decisions to adopt or diffuse innovations in the NHS.
Innovation in the NHS can take many different forms. It usually involves developing a new idea to meet a health care need. Often innovation may be related to clinical or administrative processes, but it may also involve the development of new medical technologies or clinical tools.
Examples of health care innovations might be information systems, surgical equipment, new drugs and new therapeutic uses for drugs or medical devices. An innovation does not have to be completely novel – for example, you can adopt a service development that is being done elsewhere and it is still an innovation in your organisation and in your local context.
We are interested in your experience of decision-making in the NHS and the kinds of evidence that you prioritise in your decision-making when deciding whether or not to adopt an innovation.
Taking part in this survey is voluntary. No personal details will be asked of you in this survey, and published reports about this survey will not contain any personal details
Our recently published research on the cost-effectiveness of screening for HIV in primary care has caused a great deal of interest and widespread media coverage.
We have produced a BITE sized summary of the paper with the headline findings and links to further information of interest.
The research, published in The Lancet HIV, represents the first time a model to explore the cost effectiveness of screening for HIV in primary care has been applied to the UK.
Our data provide the most reliable analyses to date and justify the investment needed to deliver HIV screening in primary care in the 74 localities considered to have high HIV prevalence – essentially most UK metropolitan areas.
Researcher and practicing GP Dr Werner Leber from Queen Mary University London said:
“We’ve shown that HIV screening in UK primary care is cost effective and potentially cost saving, which is contrary to widespread belief. This is an important finding given today’s austerity. Financial pressures, particularly within local authority’s public health budgets, mean that the costs of HIV testing are under intense scrutiny, and in some areas investment in testing has fallen.”